Optimizing Tumor-Reactive &ggr;&dgr;T Cells for Antibody-Based Cancer Immunotherapy

By  

Current Molecular Medicine, Vol. 10, Iss. 8, 2010-11 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein

By Kumar V.  

Research in Immunology, Vol. 149, Iss. 9, 1998-11 ,pp. : 827-834

Elsevier

Access to resources Recommend Favorite

Tuning T cell activation threshold and effector function with cross-reactive peptide ligands

By Nicholson L.B.   Anderson A.C.   Kuchroo V.K.  

International Immunology, Vol. 12, Iss. 2, 2000-02 ,pp. : 205-213

Oxford University Press

Access to resources Recommend Favorite

Editorial. Inhibition of thymidine synthesis by folate analogues induces a Fas–Fas ligand-independent deletion of superantigen-reactive peripheral T cells

By Izeradjene K.   Revillard J-P.   Genestier L.  

International Immunology, Vol. 13, Iss. 1, 2001-01 ,pp. : 85-93

Oxford University Press

Access to resources Recommend Favorite

Cross-reactivity and T-cell Receptor Antagonism of Myelin Basic Protein-reactive T cells is Modulated by the Activation State of the Antigen Presenting Cell

By Kissler S.   Anderton S.M.   Wraith D.C.  

Journal of Autoimmunity, Vol. 19, Iss. 4, 2002-12 ,pp. : 183-193

Academic Press

Access to resources Recommend Favorite